MindWave Innovations Inc. USA, a wholly owned subsidiary of Apimeds Pharmaceuticals US, Inc. (NYSE American: APUS), has entered into a two-year master maintenance and service agreement with BlockAssure Inc. to build, deploy, and operate AssureChain, a dedicated subnet of MindChain tailored for BlockAssure's insurance and reinsurance operations. The agreement, effective October 4, 2026, positions MindWave as BlockAssure's exclusive blockchain provider for AssureChain during the term and marks a significant step in applying blockchain infrastructure to the insurance sector.
Under the agreement, MindWave will design, develop, security-audit, and deploy AssureChain, and will subsequently host, operate, and maintain the network. AssureChain is intended to support a range of insurance-related functions, including contracts, policies, premium and payment entries, reinsurance treaties, and claims processing. MindChain will serve as the settlement layer, anchoring AssureChain records to Ethereum, which enhances transparency and traceability.
In return, MindWave will receive contracted development fees payable in quarterly installments, with operating and maintenance fees to be agreed upon later. Additionally, MindWave will receive an allocation equal to 20% of the total supply of AssureCoin, a planned digital token within the MindChain network. This allocation could provide MindWave with a stake in the tokenized ecosystem, potentially aligning its interests with the success of AssureChain.
The development is planned over four quarters, with an automatic renewal for one-year periods after the initial two-year term unless either party provides 90 days' notice. This structure suggests a long-term commitment to the project and confidence in its potential to transform insurance operations through blockchain technology.
The agreement matters because it demonstrates the growing adoption of blockchain solutions in traditional industries. By integrating blockchain into insurance and reinsurance, AssureChain aims to streamline processes, reduce fraud, and increase efficiency. For MindWave, this contract not only generates revenue but also expands its footprint in the digital-asset-enabled insurance models. It validates MindChain's capabilities and could attract other insurers seeking similar solutions.
Investors in Apimeds Pharmaceuticals may view this as a positive development, as it diversifies the company's offerings and taps into the burgeoning blockchain market. The news was distributed by CryptoCurrencyWire, a specialized communications platform focusing on blockchain and cryptocurrency. CryptoCurrencyWire is part of the Dynamic Brand Portfolio at IBN, which provides extensive wire solutions through InvestorWire and other services.
As blockchain continues to disrupt various sectors, MindWave's agreement with BlockAssure could serve as a blueprint for future collaborations, potentially driving further innovation and investment in the space. The full press release is available at https://ccw.fm/bVeq4.
